Sefer Gezer's research topics

Sefer Gezer

Concepts (82)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with Sefer Gezer's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Sefer Gezer has written about over time.

Apoptosis, 3 publications between 1996 and 1999, average publication date October 1997. Bone Marrow, 2 publications between 1996 and 2001, average publication date March 1999. Leukemia, Myeloid, Acute, 1 publications between 2000 and 2000, average publication date July 2000. Myelodysplastic Syndromes, 6 publications between 1996 and 2004, average publication date September 2000. Antibodies, Monoclonal, 2 publications between 1996 and 2004, average publication date September 2000. Antineoplastic Agents, 2 publications between 1998 and 2004, average publication date April 2001. Anemia, 1 publications between 2001 and 2001, average publication date August 2001. Blood Transfusion, 1 publications between 2001 and 2001, average publication date August 2001. Thalidomide, 2 publications between 2001 and 2004, average publication date February 2003. Humans, 10 publications between 1996 and 2021, average publication date April 2003. Arsenicals, 1 publications between 2004 and 2004, average publication date July 2004. DNA-Binding Proteins, 1 publications between 2004 and 2004, average publication date July 2004. Drug Resistance, Neoplasm, 1 publications between 2004 and 2004, average publication date July 2004. Oxides, 1 publications between 2004 and 2004, average publication date July 2004. Proto-Oncogenes, 1 publications between 2004 and 2004, average publication date July 2004. Transcription Factors, 1 publications between 2004 and 2004, average publication date July 2004. Tumor Necrosis Factor-alpha, 1 publications between 2004 and 2004, average publication date September 2004. Lymphohistiocytosis, Hemophagocytic, 1 publications between 2008 and 2008, average publication date July 2008. Thrombosis, 1 publications between 2021 and 2021, average publication date August 2021.

Apoptosis
Bone Marrow
Leukemia, Myeloid, Acute
Myelodysplastic Syndromes
Antibodies, Monoclonal
Antineoplastic Agents
Anemia
Blood Transfusion
Thalidomide
Humans
Arsenicals
DNA-Binding Proteins
Drug Resistance, Neoplasm
Oxides
Proto-Oncogenes
Transcription Factors
Tumor Necrosis Factor-alpha
Lymphohistiocytosis, Hemophagocytic
Thrombosis

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Apoptosis	3	1996	1999	October 1997
Bone Marrow	2	1996	2001	March 1999
Leukemia, Myeloid, Acute	1	2000	2000	July 2000
Myelodysplastic Syndromes	6	1996	2004	September 2000
Antibodies, Monoclonal	2	1996	2004	September 2000
Antineoplastic Agents	2	1998	2004	April 2001
Anemia	1	2001	2001	August 2001
Blood Transfusion	1	2001	2001	August 2001
Thalidomide	2	2001	2004	February 2003
Humans	10	1996	2021	April 2003
Arsenicals	1	2004	2004	July 2004
DNA-Binding Proteins	1	2004	2004	July 2004
Drug Resistance, Neoplasm	1	2004	2004	July 2004
Oxides	1	2004	2004	July 2004
Proto-Oncogenes	1	2004	2004	July 2004
Transcription Factors	1	2004	2004	July 2004
Tumor Necrosis Factor-alpha	1	2004	2004	September 2004
Lymphohistiocytosis, Hemophagocytic	1	2008	2008	July 2008
Thrombosis	1	2021	2021	August 2021

Gezer's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (82)

Explore

Co-Authors (5)

Explore

Similar People (60)

Explore

Same Department

Explore